A major factor contributing to this market growth is growing prevalence of asthma and chronic obstructive pulmonary diseases. Worldwide, Inhalation Systems market has also been witnessing the emergence of sophisticated inhaler devices. However, the ban on chlorofluorocarbon-based propellants could pose a challenge to the growth of this market.
This report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), and Nebulizers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this market space include AstraZeneca PLC, GlaxoSmithKline plc, Sunovion Pharmaceuticals Inc. and 3M Drug Delivery Systems
Key questions answered in this report:
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 AstraZeneca plc
11.2 GlaxoSmithKline plc
11.3 Sunovion Pharmaceuticals Inc.
11.4 3M Drug Delivery Systems Division
12. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Inhalation Systems Market 2010-2014 (US$ billion)
Exhibit 2: Global Inhalation Systems Market by Geographical Segmentation 2010
Exhibit 3: Global Inhalation Systems Market by Product Segmentation 2010-2014 (US$ billion)
Exhibit 4: Global Inhalation Systems Market by Vendor Segmentation 2010
This report has been prepared based on an in-depth analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Metered Dose Inhalers (MDI), Dry Powder Inhalers (DPI), and Nebulizers market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Inhalation Systems Market Report
Published: February 2012No. of Pages: 31
Price: Single User License: US$1500 Corporate User License: US$2500
Key questions answered in this report:
- What will the market size be in 2014 and at what rate will it grow?
- What key trends is this market subject to?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the opportunities and threats faced by each of these key vendors?
- What are the strengths and weaknesses of each of these key vendors?
01. Executive Summary
02. Introduction
03. Market Coverage
04. Market Landscape
05. Vendor Landscape
06. Buying Criteria
07. Market Growth Drivers
08. Drivers and their Impact
09. Market Challenges
10. Market Trends
11. Key Vendor Analysis
11.1 AstraZeneca plc
11.2 GlaxoSmithKline plc
11.3 Sunovion Pharmaceuticals Inc.
11.4 3M Drug Delivery Systems Division
12. Other Reports in this Series
List of Exhibits:
Exhibit 1: Global Inhalation Systems Market 2010-2014 (US$ billion)
Exhibit 2: Global Inhalation Systems Market by Geographical Segmentation 2010
Exhibit 3: Global Inhalation Systems Market by Product Segmentation 2010-2014 (US$ billion)
Exhibit 4: Global Inhalation Systems Market by Vendor Segmentation 2010
